a public good project by the
Synthesis
Company
of California

© 2026

Antonio Laurenza | doi.page

0 works0 citations0 h-index

Antonio Laurenza

Takeda (United States)(US)Takeda (Japan)(JP)

Publications by Year

Research Areas

Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Neuroscience and Neuropharmacology Research, Pharmaceutical studies and practices, Neurological disorders and treatments

Most-Cited Works

→ Adjunctive perampanel for refractory partial-onset seizures(2012)473 cited
→ Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?(1989)457 cited
→ Randomized phase III study 306(2012)425 cited
→ Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305(2012)423 cited
→ Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy(2015)326 cited
→ A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents(2000)280 cited

→ Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies(2013)

260 cited

→ Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel(2015)133 cited

→ Naratriptan is effective and well tolerated in the acute treatment of migraine(1997)132 cited

→ Perampanel, a selective, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial‐onset seizures: Interim results from phase III, extension study 307(2012)116 cited